2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$17.80-$0.10 (-0.56%)
Price as of Jul 14, 2026 4:48 AM EDT- $5.8BMarket Cap
- 1,126.03%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$17.80-$0.10 (-0.56%)
ERAS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.90 | ||
Change | -$0.63 (-3.40%) | ||
Open | $18.44 | ||
High | $18.50 | ||
Low | $17.63 | ||
Previous Close | $18.53 | ||
Volume | 2,555,112 | ||
30-Day Average Volume | 5,804,285 | ||
1-Week Change | -5.04% | ||
1-Month Change | 27.40% | ||
1-Year Change | 1,126.03% | ||
3-Year Change | 560.52% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 311.0M | ||
Total Assets | $461.2M | ||
Market Cap | $5.8B | ||
Enterprise Value | $5.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$183.4M | ||
Free Cash Flow | -$27.4M | ||
EBIT | -$183.4M | ||
EBITDA | -$182.7M | ||
Net Working Capital | $227.1M | ||
EPS | -$0.60 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -31 | ||
PEG | 0 | ||
Price/Free Cash Flow | -210 | ||
Price/Operating Cash Flow | -210 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue